Overview of Cataflam Fast

Property	Description
Active ingredient	Diclofenac Potassium
Form	Powder for oral solution (Sachet)
Pharmacological class	Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose	Relief of acute pain, inflammation, and fever
Origin	Synthetic (Phenylacetic acid derivative)

What Type of Medicine is Cataflam Fast?

Cataflam Fast is classified as a potent Nonsteroidal Anti-inflammatory Drug (NSAID) whose active component is Diclofenac, specifically the highly soluble form known as diclofenac potassium. This medicine belongs to the phenylacetic acid class of compounds, chemically distinguishing it from other NSAIDs. The drug is a fully synthetic derivative designed for oral administration, known pharmacologically as an inhibitor of cyclooxygenase enzymes. Diclofenac possesses recognized anti-inflammatory and analgesic properties. This medicine is intended to reduce inflammation and relieve pain, consistent with its pharmacological classification.

Why is Diclofenac Potassium Used in a 'Fast' Formulation?

The term "Fast" refers to the medication's specialized immediate-release preparation, typically supplied as a powder for oral solution packaged within a sachet. This form utilizes the rapid dissolution properties of the diclofenac potassium salt, which is inherently more soluble than the diclofenac sodium salt used in standard tablets. The primary goal of this design is to ensure the active ingredient is rapidly absorbed. The rapid absorption of the potassium salt promotes a quick onset of action. This specialized design is particularly intended for situations requiring quick symptom relief, such as an adult experiencing temporary acute discomfort. The rapid absorption is a key differentiating feature of Cataflam Fast compared to generic film-coated Diclofenac tablets.

What is the General Purpose of This Medication?

The general purpose of Cataflam Fast is to achieve a swift, simultaneous analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) effect. The medication is taken via the oral route of administration and is fundamentally useful for alleviating temporary, acute discomfort and pain that results from inflammatory processes in the body. By combining these three core physiological actions with a rapid delivery system, the medication provides comprehensive and swift symptomatic control. It is clinically recognized for its reliable action in cases where immediate relief from intense, temporary pain is required.

What side effects are possible with Cataflam Fast?

Possible Side Effects and Safety Information

Cataflam Fast, which contains the active ingredient diclofenac potassium, is a Nonsteroidal Anti-inflammatory Drug (NSAID) used for short-term pain relief. Like all medicines, it may cause side effects, though not everyone experiences them.

Serious Warnings and Risks

As an NSAID, Cataflam Fast carries important safety risks you should be aware of:

Cardiovascular Risk: NSAIDs may increase the risk of serious cardiovascular thrombotic events, including heart attack and stroke, which can be fatal. This risk may occur early in treatment and may increase with the duration of use and higher doses.
Gastrointestinal Risk: There is an increased risk of serious gastrointestinal events, including inflammation, bleeding, ulceration, and perforation of the stomach or intestines, which can also be fatal. These can occur at any time without warning symptoms.

Seek immediate medical attention if you experience symptoms like chest pain, shortness of breath, sudden weakness or slurred speech, or if you have signs of stomach bleeding (black or tarry stools, vomiting blood).

Common Side Effects

The most frequent side effects often relate to the digestive system, generally affecting 1% to 10% of users. These may include:

System	Common Side Effects (1%-10% Frequency)
Gastrointestinal	Nausea, vomiting, diarrhea, indigestion, stomach pain, gas
Nervous System	Headache, dizziness, drowsiness
General	Fluid retention (edema), rash, tinnitus (ringing in the ears), elevated blood pressure

Inform your healthcare provider if any of these common side effects are persistent or bothersome. Other rare but serious effects can involve the liver (jaundice, liver enzyme elevation) or kidneys (change in urine output, swelling of legs/ankles) and require urgent medical consultation.

Overdose and Emergency Response

Overdose Symptoms and When to Seek Help

A diclofenac potassium overdose is formally documented by regulatory authorities as typically presenting with a specific range of symptoms across two main physiological systems. Initial signs often involve gastrointestinal distress such as nausea, vomiting, and pain in the upper abdomen (epigastric pain). Central nervous system symptoms may also manifest, including states of dizziness, headache, lethargy, and disorientation. Severe cases may escalate to more serious neurological events like convulsions and, rarely, coma.

Severe Outcomes and Required Actions Life-threatening outcomes such as acute renal failure, liver damage, and gastrointestinal bleeding are cited in regulatory labeling as potential complications following a significant overdosage. Due to the risk of these severe, delayed effects, the official guidance states that one must seek immediate medical attention upon the suspicion or known ingestion of an overdose amount.

Supportive Care and Constraints Regulatory documents confirm that no specific antidote is known for a diclofenac overdose. Therefore, clinical management focuses on supportive and symptomatic treatment. Medical professionals may consider procedures such as gastric lavage and the administration of activated charcoal shortly after a large ingestion to help reduce absorption. It is also noted in regulatory information that children may be at an increased risk of developing convulsions in an overdose scenario.

Therapeutic Uses of Cataflam Fast

Cataflam Fast: Main Uses and Benefits

Cataflam Fast, containing diclofenac potassium, is commonly used to help with the acute relief of pain and inflammation across several medical domains, aiming to ease the overall symptom burden. The therapeutic focus is on managing symptoms related to inflammatory or irritative states.

The medication may be part of symptomatic management across the musculoskeletal domain to ease pain and stiffness associated with flare-ups of conditions like osteoarthritis and rheumatoid arthritis. It is also relevant for supportive symptom management of post-traumatic discomfort from sprains or strains, as well as post-operative swelling and pain. Furthermore, it is used to manage episodic pain such as acute migraine attacks and primary dysmenorrhea (menstrual cramps), and to ease pronounced discomfort from conditions like dental pain or inflammatory ENT infections.

This short-term symptomatic assistance helps improve day-to-day comfort during symptomatic periods, with the core therapeutic aim being to moderate multiple distressing symptoms simultaneously.

“The therapeutic aim of this medicine is to assist the patient during difficult, acute episodes by contributing to easing the burden of symptoms that interfere with routine activities.”

Quick Fact: Relief for Acute Discomfort and Inflammation

The medication is relevant when supportive symptom management is appropriate for conditions characterized by periods of heightened symptoms and is applied in scenarios where additional management of discomfort, swelling, and fever may be beneficial.

Regulatory References

DailyMed listing reviewed by the FDA

Eligibility and Restrictions for Use

Cataflam Fast, which contains the active ingredient diclofenac potassium, is generally used for the short-term relief of mild to moderate pain and inflammation, such as that caused by sprains, strains, dental surgery, or menstrual pain.

However, as a nonsteroidal anti-inflammatory drug (NSAID), it is not suitable for everyone and carries a risk of serious side effects, particularly affecting the gastrointestinal and cardiovascular systems. Always consult a healthcare professional before use.

Contraindications (Who Should NOT Use Cataflam Fast)

Condition/History	Reason for Caution/Contraindication
Allergies	Known allergy or hypersensitivity to diclofenac, aspirin, or other NSAIDs (risk of severe allergic reactions like asthma attacks, hives, or anaphylaxis).
Gastrointestinal	Active stomach or intestinal ulcer, bleeding, or perforation.
Cardiovascular	Established congestive heart failure (NYHA Class II-IV), ischemic heart disease, peripheral arterial disease, or cerebrovascular disease (e.g., history of stroke).
Surgery	For the treatment of pain right before or after coronary artery bypass graft (CABG) surgery.
Kidney/Liver	Severe renal or hepatic (liver) failure.
Pregnancy	Last three months (third trimester) of pregnancy.
Age	Generally not recommended for children and adolescents under 14 years of age.

Use with Caution

Particular caution and medical supervision are required for individuals with risk factors for heart disease (e.g., high blood pressure, diabetes, high cholesterol, smoking), mild to moderate kidney or liver problems, a history of gastrointestinal issues, Crohn's disease, or ulcerative colitis.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific interaction constraints for Diclofenac Potassium (Cataflam Fast). Use is strictly contraindicated for treating pain following Coronary Artery Bypass Graft (CABG) surgery. Co-administration with other systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, should be avoided due to the increased potential for additive gastrointestinal undesirable effects.

Several medicinal product classes increase risks via pharmacodynamic reinforcement. Taking Cataflam Fast with Anticoagulants (e.g., Warfarin), Anti-platelet agents, or SSRIs/SNRIs raises the potential for bleeding. Co-administration with Diuretics or Antihypertensive agents (e.g., ACE inhibitors) can reduce their therapeutic effect and increase the risk of worsening renal function.

Diclofenac is known to modify the exposure of certain drugs. It may raise the plasma concentrations of Lithium and Digoxin, often requiring therapeutic monitoring. Interactions also occur through metabolic pathways, where certain medicines (e.g., Alpelisib, Atazanavir) can alter Diclofenac exposure via CYP and UGT enzyme inhibition or induction.

Food and Timing Rules: The powder for oral solution must be taken on an empty stomach. Taking it with food causes a delayed onset of absorption and a reduction in peak plasma concentration ( C max). Official warnings also note that consuming Alcohol may increase the risk of serious gastrointestinal problems.

Mechanism of Action

Enzyme Blockade and Prostaglandin Suppression

The primary mechanism involves acting as a non-selective competitive inhibitor of the Cyclooxygenase (COX) enzymes ( COX-1 and COX-2). By blocking the action of these enzymes, the medicine curbs the synthesis of prostaglandins, particularly PGE2, which are lipid mediators that contribute to the amplification of physiological responses. This action is central to the modulation of downstream biochemical events.

Modulation of Neural and Thermal Signaling

The reduction in PGE2 concentration leads to a predictable mechanistic cascade that influences key regulatory systems. Peripherally, lower PGE2 levels prevent the sensitization of nociceptors (pain-sensing nerves), thus modulating the transmission of afferent neuronal signals. Centrally, the same inhibitory action within the hypothalamus interferes with the resetting of the hypothalamic temperature set point.

Mechanism Speed and Pathway Constraints

The accelerated enzyme inhibition achieved by this formulation is a mechanism-dependent consequence of the diclofenac potassium salt, which promotes rapid absorption and fast establishment of the blockade. The mechanism is selectively constrained to the prostanoid pathway, meaning its scope of action does not extend to physiological processes driven primarily by mediators from the non-inhibited Lipoxygenase (LOX) pathway (e.g., leukotrienes).

Dosage and Administration Information

How to Use Cataflam Fast

This section describes the administration for Cataflam Fast (diclofenac potassium powder for oral solution), detailing the usage guidelines.

Administration and Dosing

Cataflam Fast is for oral administration only. The contents of the single-dose sachet (containing 50 mg of diclofenac potassium) must be prepared as a solution prior to intake.

Administration Component	General Guidelines
Preparation	Empty the sachet into a cup with 1 to 2 ounces (30 to 60 mL) of water. Mix well and drink immediately.
Dilution Restriction	Do not use liquids other than water for mixing the powder.
Timing	For optimal effect and absorption, the solution should be taken preferably before meals or on an empty stomach.
Standard Adult Dose	Initial daily dose typically 100 to 150 mg (2 to 3 sachets), divided into separate doses. The dose for acute migraine treatment is 50 mg (one sachet) initially, with a further 50 mg possible after 2 hours.
Maximum Daily Dose	The total dose should not exceed 200 mg per day for the acute treatment of conditions such as migraine or dysmenorrhea.

Usage Duration and Age Rules

This diclofenac potassium formulation is for short-term treatment only. The usage pattern is defined by the specific acute condition being managed, such as continuing for a few days for primary dysmenorrhea.

Age Restriction: This 50 mg powder formulation is not recommended for use in children and adolescents below 14 years of age.

Recent Clinical Evidence

Research evidence / Overview of studies for Cataflam Fast

Evidence for Use in Acute Postoperative Pain

Research has investigated this immediate-release formulation in adults included in the study for moderate to severe pain following minor surgical procedures. These trials, often short-term Randomized Controlled Trials (RCTs), primarily focused on outcomes related to physical discomfort during the immediate recovery phase. Studies monitored the time participants sought additional pain relief, reporting that a greater number of participants receiving the immediate-release formulation achieved the predefined benchmark for change in pain metrics compared to those receiving a placebo.

Evidence for Use in Acute Migraine Attacks

The research landscape includes randomized, double-blind trials evaluating the medication for acute headache management in adults. These studies explored outcomes describing episodic or acute changes, primarily examining achieving a measured absence of pain at 2 hours post-dose and remaining free of associated symptoms, such as nausea or sensitivity to light, at that time point. Studies monitored the recurrence of headache pain within 24 hours of the initial dose across different trial arms.

Evidence for Primary Dysmenorrhea and Musculoskeletal Pain

For primary dysmenorrhea, research utilized controlled clinical trials focusing on outcomes capturing phases of heightened symptom activity, examining the measurement of menstrual pain intensity using standard rating scales. The research structure for acute pain and inflammation in musculoskeletal disorders is supported by the evidence base for systemic diclofenac, which contributes to the broader evidence landscape alongside specific acute-model RCTs for the fast-acting formulation.

Areas of Research Uncertainty and Gaps

Most key efficacy trials utilize very short-term follow-up durations (typically up to 24 hours). This means long-term effects are not fully established, as the research provides limited insight into effects that extend beyond this short window. Furthermore, comparative evidence is lacking for head-to-head comparisons between this specific diclofenac potassium formulation and the numerous other pain relief products available. Research studies explored pharmacokinetic outcomes in specialized adult populations, but data for certain groups remain insufficient to draw specific conclusions about unique efficacy patterns.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Cataflam Fast (FAQ)

Q: Is Cataflam Fast the same type of medicine as regular Cataflam?

The primary difference between Cataflam Fast and standard diclofenac formulations is the salt component attached to the active ingredient, diclofenac. Cataflam Fast uses diclofenac potassium, which is a highly soluble form designed for rapid absorption by the body. Standard formulations, sometimes called 'regular Cataflam,' often contain diclofenac sodium. Both formulations contain the same active anti-inflammatory substance.

Q: Is Cataflam Fast available in different strengths?

According to official product information, the Cataflam Fast powder for oral solution is supplied as single-dose sachets containing 50 mg of the active ingredient, diclofenac potassium. Other formulations of diclofenac, such as tablets, may be available in different strengths under various brand names.

Q: What does 'diclofenac potassium' mean in patient-friendly terms?

The drug's name describes its key components: Diclofenac is the non-steroidal anti-inflammatory drug (NSAID) that provides the pain and inflammation relief. The potassium component is a salt that is added to the diclofenac to help it dissolve very quickly in water. This specialized salt form ensures the active ingredient is rapidly absorbed, contributing to the 'Fast' action.

Q: Are there research studies comparing the onset of action of Cataflam Fast to standard diclofenac?

Yes, studies reviewed during the regulatory evaluation of this product focus on the pharmacokinetics, which is how the body handles the drug. These studies indicate that the diclofenac potassium formulation has a more rapid rate of absorption compared to standard diclofenac tablets. This difference in absorption supports the claim of a quicker onset of action.

Q: Does Cataflam Fast interact with common over-the-counter cold medicines?

Official product information includes a warning against taking this drug with other systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Many common over-the-counter cold and flu medicines contain NSAIDs like ibuprofen or naproxen, and combining them is generally not recommended due to the potential for an increased risk of serious side effects.

Q: Is there a maximum number of days the drug is intended to be used?

According to regulatory documents, this formulation is approved only for short-term treatment of acute conditions. The duration of use is defined by the specific pain being managed, such as for a few days for primary dysmenorrhea. Official guidance emphasizes that the medication is intended for use at the lowest effective dose and for the shortest possible duration to manage acute symptoms.

Q: Can Cataflam Fast be taken while also using aspirin?

Co-administration with other NSAIDs, including aspirin used for general pain relief, is generally not recommended due to the potential for an increased risk of adverse effects, such as gastrointestinal bleeding. If a patient is taking low-dose aspirin for cardiovascular protection, caution is required due to the potential for increased bleeding risk.

Q: Does Cataflam Fast carry a specific boxed warning from regulatory agencies?

Yes, official product labeling from the FDA includes a specific Boxed Warning (also called a Black Box Warning) as mandated for all systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs). This warning highlights the potential for serious cardiovascular risks, such as heart attack and stroke, and serious gastrointestinal risks, including bleeding or perforation of the stomach.

Q: How long does the effect of Cataflam Fast usually last?

While official sources do not state a precise duration of effect for every patient, the pharmacokinetics of the active ingredient, diclofenac, can provide insight. The plasma elimination half-life, which is a measure of how quickly the drug is cleared from the body, is generally reported to be approximately 1 to 2 hours.

Q: Does taking Cataflam Fast affect my ability to drive or operate machinery?

Official labeling states that patients who experience side effects such as dizziness, drowsiness, vertigo, or vision changes should refrain from driving or operating machinery. These effects are related to the central nervous system activity of the medication.

Q: Is Cataflam Fast generally described as safe for older adults?

Official information from regulatory sources notes that older adults are at a greater risk for serious side effects, particularly those affecting the gastrointestinal tract. Due to this increased risk, official documents emphasize the importance of using the lowest effective dose for the shortest possible time in this population.

Q: Can someone who is lactose intolerant use Cataflam Fast?

Official regulatory documents list all inactive ingredients (excipients). Depending on the specific formulation, the product may contain lactose as a filler. The presence of lactose is relevant for individuals with known rare hereditary issues, such as galactose intolerance or severe lactose deficiencies.

Q: Does the medicine come with a specific warning about skin reactions?

Yes, the official labeling includes a serious warning regarding rare but severe skin reactions that have been reported with NSAIDs, which can be life-threatening. These include conditions like exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN).

Q: Is Cataflam Fast known to interact with birth control pills?

Official sources do not typically list hormonal contraceptives as a primary interaction requiring specific dosage changes. However, diclofenac is processed by the CYP2C9 enzyme pathway in the liver, which is also involved in the metabolism of certain hormones.

Q: What is the expected half-life of the active ingredient in Cataflam Fast?

According to pharmacokinetic data in official regulatory documents, the terminal half-life of the active ingredient, diclofenac, is reported to be approximately 1 to 2 hours. The half-life is a measure of the time required for the concentration of the drug in the bloodstream to be reduced by half.

Q: Is there published information about Cataflam Fast use during breastfeeding?

Official regulatory documents confirm that the active ingredient, diclofenac, is excreted in breast milk in small amounts. As a precautionary measure, the use of the drug is generally not recommended during breastfeeding.

Q: Is Cataflam Fast suitable for people with gluten sensitivities?

Official sources provide a complete list of inactive ingredients (excipients). Manufacturers generally do not use wheat starch or other specific gluten-containing compounds, suggesting the product may be considered gluten-free. However, regulatory caution suggests reviewing the full excipient list for individuals with severe gluten sensitivities.

Q: Is there a known risk of dependence or addiction with Cataflam Fast?

Cataflam Fast is classified as a Non-Steroidal Anti-inflammatory Drug (NSAID), not a narcotic or opioid pain reliever. Accordingly, official regulatory documents state that the drug is not listed as a controlled substance, and its pharmacological classification does not indicate a risk of dependence or addiction.

Q: What are the components of the inactive ingredients listed for Cataflam Fast?

Official regulatory documentation, such as the Summary of Product Characteristics (SmPC), provides a complete list of all inactive ingredients (excipients) used in the formulation. These ingredients typically include substances such as flavoring agents, sweeteners (such as aspartame), and fillers.

How should Cataflam Fast be stored and disposed of?

Storage and Disposal of Cataflam Fast

Cataflam Fast (diclofenac potassium powder for oral solution) must be stored under specific regulatory conditions to maintain its efficacy and prevent accidental exposure.

Storage Requirements

This medicine must be kept at controlled room temperature, specifically between 20° to 25°C (68° to 77°F). It is required to protect the powder from freezing, excessive heat, moisture, and direct light. The product should be stored in a closed container and must always be kept out of the reach and sight of children.

Disposal Instructions

Unused or expired product should be discarded following official guidelines, such as a drug take-back program. If a take-back option is unavailable, the medicine should be mixed with an unappealing substance and sealed before discarding in household trash. It is explicitly required to avoid environmental release, meaning the product should not be disposed of in wastewater.

Cataflam Fast